SCHEMBL2956960

SCHEMBL2956960

CCCCCCCCCCCCCCc1ccncc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.63
LMNA P02545 3/20 0.57
ESR1 P03372 2/20 0.57
ADRA2A P08913 2/20 0.57
ADORA3 P0DMS8 2/20 0.57
TACR2 P21452 2/20 0.57
SLC6A2 P23975 2/20 0.57
SLC6A4 P31645 2/20 0.57
SLC6A3 Q01959 2/20 0.57
KDM4E B2RXH2 1/20 0.57
ALDH1A1 P00352 1/20 0.57
SHBG P04278 1/20 0.57
TP53 P04637 1/20 0.57
CYP3A4 P08684 1/20 0.57
HSPD1 P10809 1/20 0.57
ADRB3 P13945 1/20 0.57
HTR2C P28335 1/20 0.57
HSPE1 P61604 1/20 0.57
HIF1A Q16665 1/20 0.57
TST Q16762 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1878164 1.00 HRH1 (0.63) HRH1LMNAESR1ADRA2AADORA3
SCHEMBL6870191 1.00 HRH1 (0.63) HRH1LMNAESR1ADRA2AADORA3
SCHEMBL214898 1.00 HRH1 (0.63) HRH1LMNAESR1ADRA2AADORA3
SCHEMBL2956596 1.00 HRH1 (0.63) HRH1LMNAESR1ADRA2AADORA3
SCHEMBL25380899 1.00 HRH1 (0.63) HRH1LMNAESR1ADRA2AADORA3
SCHEMBL25379522 1.00 HRH1 (0.63) HRH1LMNAESR1ADRA2AADORA3
SCHEMBL1262477 1.00 HRH1 (0.63) HRH1LMNAESR1ADRA2AADORA3
SCHEMBL2959380 1.00 HRH1 (0.63) HRH1LMNAESR1ADRA2AADORA3
SCHEMBL2953743 1.00 HRH1 (0.63) HRH1LMNAESR1ADRA2AADORA3
SCHEMBL2957269 1.00 HRH1 (0.63) HRH1LMNAESR1ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116323712-B Alkali releasing composition and curable resin composition using same 纳美仕有限公司 2024-09-03 CN disclosed
WO-2024098840-A1 ISOBUTYLENE-BASED CATIONIC SALT POLYMER, PREPARATION METHOD THEREFOR, USE THEREOF, AND ANTIBACTERIAL POLYMER MATERIAL 中国石油化工股份有限公司 2024-05-16 WO disclosed
CN-118027254-A Isobutylene pyridine salt ionic polymer, preparation method and application thereof, and antibacterial high polymer material 中国石油化工股份有限公司 2024-05-14 CN disclosed
US-20230399550-A1 BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING THE SAME NAMICS CORPORATION (JP) 2023-12-14 US disclosed
EP-4239025-A1 BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING SAME Namics Corporation (JP) 2023-09-06 EP disclosed
CN-116323712-A Alkali releasing composition and curable resin composition using same 纳美仕有限公司 2023-06-23 CN disclosed
WO-2022091989-A1 BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING SAME ナミックス株式会社 2022-05-05 WO disclosed
EP-2100589-B1 4-Alkyl substituted pyridines as olfactory substances SYMRISE AG (DE) 2017-07-26 EP disclosed
US-8865634-B2 4-alkyl substituted pyridines as odiferous substances SYMRISE AG (DE) 2014-10-21 US disclosed
US-20100130624-A1 4-ALKYL SUBSTITUTED PYRIDINES AS ODIFEROUS SUBSTANCES SYMRISE GMBH & CO. KG (DE) 2010-05-27 US disclosed
EP-2100589-A1 4-Alkyl substituted pyridines as olfactory substances Symrise GmbH & Co. KG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130624-A1 4-ALKYL SUBSTITUTED PYRIDINES AS ODIFEROUS SUBSTANCES CYP4A22, CYP4X1, CYP4B1 HRH1 2655/4885LMNA 3493/4885ESR1 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.